AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2007
Jan 8, 2007
31801_dirs_2007-01-08_2c791d2f-bde2-4ab5-927f-eb3ad4a34b2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVANT IMMUNOTHERAPEUTICS INC (AVAN)
CIK: 0000744218
Period of Report: 2007-01-05
Reporting Person: Keilani Taha (VP Medical & Reg Affairs)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-01-05 | Incentive Stock Option | $1.355 | A | 15000 | Acquired | 2017-01-05 | Common Stock (15000) | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Mar 26